Breast cancer remains a significant health concern in Indonesia, with 66,271 new cases reported in 2022, accounting for 16.2% of all new cancer cases in the country. The mortality rate is equally alarming, with over 22,598 deaths attributed to breast cancer, underscoring the critical need for early detection and effective screening methods.

Addressing this pressing issue, Ciputra Hospital Surabaya has partnered with GE Healthcare to introduce the Automated Breast Ultrasound System (ABUS), a cutting-edge technology designed to enhance early detection of breast cancer. ABUS performs rapid and precise automatic 3D scans, producing high-quality images that facilitate the identification of abnormalities or changes in breast tissue. This advancement enables quicker and more accurate diagnoses, which are vital for effective treatment outcomes.

Dr. Desak Gede Agung Suprabawati, an Oncology Surgeon Specialist at Ciputra Hospital, highlights the benefits of ABUS, noting that it offers a comfortable, radiation-free screening option. This is particularly advantageous for women under 40, pregnant women, patients with implants, and individuals sensitive to radiation. While mammography is the traditional gold standard for breast cancer detection, its efficacy can be limited in women with dense breast tissue. In such cases, ABUS provides a more effective alternative, as dense tissue can obscure potential issues in mammographic images.

Radiology Specialist Dr. Sidharta emphasizes the importance of understanding breast cancer risk factors and symptoms. He notes that delays in early detection often result in patients presenting at more advanced stages of the disease. ABUS technology has demonstrated the capability to increase the detection rate of invasive breast cancer by up to 55% compared to mammography alone, making it a valuable tool in the fight against breast cancer.

The collaboration between Ciputra Hospital and GE Healthcare extends beyond technology implementation; it also focuses on public education. Through health talks and talk shows, the partnership aims to raise awareness about the importance of regular self-breast examinations (SADARI) and provide comprehensive information about breast cancer. These initiatives include hospital tours and breast cancer screenings, fostering a proactive approach to health within the community.

Ferranus Rachmawati, Product Manager of Breast Ultrasound at GE Healthcare Indonesia, expresses that the introduction of ABUS at Ciputra Hospital reinforces their commitment to supporting government efforts in enhancing public health services, particularly in early breast cancer detection. Notably, Ciputra Hospital is the first medical facility in East Java to adopt this advanced technology, marking a significant milestone in regional healthcare.

This initiative aligns with GE Healthcare's global campaign, 'Don't Skip,' which encourages women worldwide to undergo regular breast examinations. The launch of ABUS technology at Ciputra Hospital Surabaya aims to elevate public awareness about the importance of early breast cancer detection and to provide high-quality health services to the community.

In conclusion, the integration of ABUS technology at Ciputra Hospital Surabaya represents a significant advancement in breast cancer screening capabilities. By offering enhanced detection methods, particularly for women with dense breast tissue, and emphasizing public education, this collaboration sets a new standard in the early identification and treatment of breast cancer in Indonesia.